Example: Heart Attack

Clinical Trials on Anaplastic Thyroid Cancer

Total 65 results

NCT02726503

Completed

Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer

Conditions: Anaplastic Thyroid Cancer
NCT04574817

Not yet recruiting

Study of HX008 for the Treatment of Anaplastic Thyroid Cancer (ATC)

Conditions: Anaplastic Thyroid Cancer
NCT03085056

Recruiting

Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer

Conditions: Anaplastic Thyroid Cancer
NCT01774279

Recruiting

interNational Anaplastic Thyroid Cancer Tissue Bank and Database (iNATT)

Conditions: Anaplastic Thyroid Cancer
NCT02516774

Withdrawn

A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers

Conditions: Anaplastic Thyroid Cancers
NCT00280852

Completed

Review of Multimodality Management of Anaplastic Thyroid Cancer

Conditions: Anaplastic Thyroid Cancer
NCT03122496

Active, not recruiting

Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer

Conditions: Metastatic Anaplastic Thyroid Cancer
NCT01701349

Withdrawn

Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer

Conditions: Anaplastic Thyroid Cancer
NCT02244463

Recruiting

A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer

Conditions: Anaplastic Thyroid Cancer; Thyroid Cancer
NCT03565536

Unknown status

Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer

Conditions: Thyroid Cancer, Anaplastic
NCT02688608

Recruiting

Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer

Conditions: Anaplastic Thyroid Cancer
NCT00507429

Terminated

Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer

Conditions: Anaplastic Thyroid Cancer
NCT01240590

Completed

A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)

Conditions: Solid Tumor; Anaplastic Thyroid Cancer
NCT02152137

Active, not recruiting

Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer

Conditions: Anaplastic Thyroid Cancer; Recurrent Thyroid Cancer
NCT02657369

Terminated

A Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC)

Conditions: Thyroid Carcinoma, Anaplastic
NCT00603941

Terminated

A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel

Conditions: Anaplastic Thyroid Cancer
NCT00126568

Terminated

Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer

Conditions: Anaplastic Thyroid Cancer; Recurrent Thyroid Cancer
NCT01236547

Active, not recruiting

Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer

Conditions: Thyroid Gland Anaplastic Carcinoma
NCT04420754

Recruiting

Study of AIC100 in Relapsed/Refractory Thyroid Cancer

Conditions: Anaplastic Thyroid Cancer; Relapsed/Refractory Poorly Differentiated Thyroid Cancer
NCT04238624

Recruiting

Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer

Conditions: Anaplastic Thyroid Cancer; Thyroid Cancer; BRAF Gene Mutation; BRAF Mutation-Related Tumors
NCT04552769

Recruiting

Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

Conditions: Thyroid Cancer; Anaplastic Thyroid Cancer; Undifferentiated Thyroid Cancer
NCT02289144

Withdrawn

Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer

Conditions: Metastatic Anaplastic Thyroid Cancer; Locally Advanced Anaplastic, Undifferentiated Thyroid Cancer
NCT03975231

Recruiting

Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer

Conditions: BRAF NP_004324.2:p.V600E; BRAF V600K Mutation Present; Thyroid Gland Anaplastic Carcinoma
NCT00077103

Terminated

Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer

Conditions: Head and Neck Cancer
NCT00804830

Terminated

Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer

Conditions: Thyroid Neoplasms; Carcinoma; Thyroid Cancer; Metastatic Cancer